Patient-Derived Organoids Predict Chemotherapy Efficacy for Pancreatic Cancer - Technology Networks

<i>Technology Networks</i> had the pleasure of talking to Dr. Matthew Weiss to learn more about patient-derived organoids and how these disease models could be used to develop personalized treatment strategies for pancreatic cancer.

Patient-derived cancer organoids are miniature tumors grown in the lab from donated tissue. A study presented by Dr. Matthew Weiss, professor at the Feinstein Institutes for Medical Research and depu… [+3198 chars]

full article...